Abstract
After the publication of this article, it was brought to the authors’ attention that in Fig. 1A (Characterization of DHA-SBT-1214 nanoemulsion formulation.), The transmission electron micrograph (TEM) of the placebo (NE-Placebo) and DHA-SBT-1214 nanoemulsion formulation (NE-DHA-SBT-1214) images were identical. After comparing with the original TEM data, the authors found those two images belong to DHA-SBT-1214 nanoemulsion. The corrected image for the transmission electron micrograph (TEM) of the placebo (NE-Placebo) and DHA-SBT-1214 nanoemulsion formulation (NE-DHA-SBT-1214) are shown as below. The analysis, results and conclusions of the manuscript remain valid. The authors apologize for this error.(Figure presented).
| Original language | English |
|---|---|
| Article number | 218043 |
| Journal | Cancer Letters |
| Volume | 633 |
| DOIs |
|
| State | Published - Nov 28 2025 |
Fingerprint
Dive into the research topics of 'Corrigendum to “Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 Inhibits prostate cancer stem cell-induced tumor growth” (Cancer Letters, (2017), 406, C, (71-80), (S0304383517304810), 10.1016/j.canlet.2017.08.004)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver